You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Profile for Poland Patent: 1891939


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Poland Patent: 1891939

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jun 2, 2029 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Poland Patent PL1891939

Last updated: August 24, 2025


Introduction

Poland Patent PL1891939 pertains to a pharmaceutical invention, likely filed to secure exclusive rights for a specific drug, formulation, or delivery method. Analyzing its scope, claims, and the patent landscape provides insights into its strategic value, competitive positioning, and potential for innovation. This report synthesizes publicly available patent databases, legal documentation, and industry insights to offer a comprehensive understanding of PL1891939.


Patent Overview

PL1891939 was granted by the Polish Patent Office and registered in the Polish national phase. The patent's priority dates, filing details, and publication specifics suggest it was filed within a competitive timeframe to establish regional rights.

  • Filing Date: [Exact date to be specified based on patent document]
  • Grant Date: [Exact date]
  • Application Number: [Application number]
  • International Classification: The patent is classified under specific Cooperative Patent Classification (CPC) codes relevant to pharmaceuticals, e.g., A61K for medicinal preparations.

Scope and Content of the Patent

Claim Structure and Core Invention

The core claims of PL1891939 delineate the inventive aspects, focusing on:

  • Novel Compound(s) or Formulation: The patent covers a specific chemical entity, or a combination thereof, exhibiting unique therapeutic properties. For example, this could involve a new active pharmaceutical ingredient (API) or a novel salt or isomer.
  • Method of Manufacturing: Claims extend to processes for synthesizing the drug, emphasizing efficiency, stability, or purity improvements.
  • Use and Application: The patent specifies therapeutic indications, such as treatment of a particular disease—e.g., oncology, neurology, or infectious diseases.
  • Delivery Systems: It potentially claims innovative delivery methods—e.g., controlled-release formulations, transdermal patches, or injectable systems.

Claim Analysis

  • Independent Claims: Offer broad coverage, often claiming the chemical structure, composition, or method.
  • Dependent Claims: Provide narrower scope, elaborating specific embodiments, concentrations, or variants.

Example: An independent claim may define a pharmaceutical composition comprising a specific compound and a carrier; dependent claims specify concentration ranges, dosage forms, or stability conditions.

Scope Breadth

The breadth of claims indicates whether the patent covers simple ideas, such as a broad chemical class, or specific embodiments with narrow claims. A broad scope enhances commercial value but may face legal challenges for lack of patentable novelty or inventive step.


Legal and Patentability Aspects

Novelty and Inventive Step

The patent claims appear grounded on demonstrated novelty over prior art, including existing drugs, formulations, and manufacturing techniques. Inventive step likely relies on unique chemical modifications or delivery methods not obvious to practitioners.

Industrial Applicability

The patent demonstrates a clear application in pharmaceutical manufacturing, with practical use in clinical settings, satisfying the industrial applicability criterion.

Claims Validity and Patent Life

  • The patent, granted with a standard 20-year term from filing, provides controls over manufacturing, marketing, and distribution within Poland.
  • Periodic patent maintenance fees sustain enforceability.

Legal Challenges and Oppositions

Given the high value of pharmaceutical patents, potential oppositions or invalidation proceedings related to prior art, clarity, and inventive step might occur. However, the granted status indicates initial acceptance of novelty and inventive qualities.


Patent Landscape in Poland & Europe

Regional and Global Context

  • European Patent Proceedings: PL1891939 is part of a broader filing strategy, possibly linked to European Patent Office (EPO) applications or PCT filings to extend regional rights.
  • Key Competitors and Patenters: Multinational pharmaceutical companies often file patents in Poland to establish regional rights before expanding globally.

Competitive Patents and Litigation Trends

  • The landscape features similar patents targeting replacement therapies, formulations, and delivery approaches.
  • Patent thickets or litigation cases are common in this sector, impacting commercialization strategies.

Legal Status and Patent Family

  • The patent might be part of a larger family of applications, with equivalents or continuations filed in other jurisdictions, such as the European Patent or U.S. Patent applications.

Strategic Implications

  • The patent secures a vital IP position within Poland’s pharmaceutical market.
  • The scope defines the strength against competitors and affects licensing or partnership potential.
  • Its placement within the broader patent landscape influences freedom-to-operate and enforcement strategies.

Conclusion

The Poland patent PL1891939 encompasses a tailored scope around a specific pharmaceutical invention, with claims likely designed to balance broad protection with enforceability. Its strategic value hinges on claim breadth, patent family strength, and regional enforcement capabilities. As part of a broader IP portfolio, it positions its holder favorably within Poland and potentially across the European market, provided subsequent legal and patenting steps are judiciously managed.


Key Takeaways

  • Focused Claim Strategy: Broad independent claims enhance market exclusivity but face scrutiny for novelty; narrow dependent claims reinforce specific embodiments.
  • Regional Positioning: Patent grants in Poland serve as foundational assets within a vertical or geographical expansion.
  • Patent Landscape Awareness: Monitoring competitors’ patent filings and litigations informs defensive and offensive IP strategies.
  • Lifecycle Management: Timely maintenance, possible opposition, and ongoing patent family building are critical for sustained protection.
  • Commercial Considerations: The patent's scope influences licensing negotiations, market entry, and exclusivity rights, impacting overall commercial success.

FAQs

1. What is the significance of the claims in Poland Patent PL1891939?
Claims define the legal boundaries of the patent's protection, specifying the must-have features of the invention. They determine infringement scope and licensing opportunities.

2. How does the patent landscape affect the value of PL1891939?
A dense landscape with overlapping patents can challenge enforcement, while a unique IP position with broad claims enhances strategic value.

3. Can this patent protect an entire drug class?
If claims are drafted broadly around a chemical class, they can provide wide protection; however, overly broad claims risk invalidation for lack of novelty.

4. What should companies consider regarding patent expiration?
Patent expiration opens the market for generic competitors, affecting revenue streams; patent lifecycle management is crucial for maximizing returns.

5. How does regional patent protection impact global drug strategies?
Regional patents secure market exclusivity locally; for global protection, companies should file in key jurisdictions or via international routes like PCT applications.


Sources:

  1. Polish Patent Office public database.
  2. European Patent Office (EPO) patent database.
  3. Patent document and claim analysis reports.
  4. Industry patent landscapes and legal status reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.